Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2020-07-31 2020-01-13
Drug Identification Number 02243942 02243942
Brand name TEVETEN TEVETEN
Common or Proper name EPROSARTAN EPROSARTAN
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients EPROSARTAN EPROSARTAN
Strength(s) 600MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 14x2 14x2
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-11-19 2019-11-19
Estimated end date 2020-07-28 Unknown
Actual end date 2020-07-28
Shortage status Resolved Actual shortage
Company comments
Health Canada comments